Eyedrops containing an alpha1-blocker for inhibiting myopia progression
AssigneeTsubota Laboratory, Inc.
InventorsHeonuk JEONG, Toshihide KURIHARA, Kazuo TSUBOTA
Life of this patent
Estimating the term…
Abstract
Eyedrops for suppressing myopia progression containing an α1-blocker. The α1-blocker is one or more substances selected from a group consisting of bunazosin, prazosin, urapidil, silodosin, tamsulosin, doxazosin, terazosin, naftopidil, trimazosin, indoramin, alfuzosin, moxisylyte, and corynanthine, or pharmaceutically acceptable salts thereof.
Claims8
Eyedrops for suppressing myopia progression comprising:
- an α1-blocker.
Use of a composition containing an α1-blocker as eyedrops for suppressing myopia progression.
Use of a composition containing an α1-blocker for manufacture of eyedrops for suppressing myopia progression.
A myopia progression suppressing method comprising:
- administering a composition containing an α1-blocker as eyedrops for suppressing progression.
Dependencies are inferred from the claim text.